oxazolidin-2-one has been researched along with Koch's Disease in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.26) | 18.7374 |
1990's | 1 (2.13) | 18.2507 |
2000's | 15 (31.91) | 29.6817 |
2010's | 24 (51.06) | 24.3611 |
2020's | 5 (10.64) | 2.80 |
Authors | Studies |
---|---|
Lu, H; Wang, H; Zhang, D; Zhao, H | 1 |
Kamoshita, F; Karaushi, H; Mitsutake, K; Miyawaki, Y; Seki, M; Watanabe, N | 1 |
Aragaw, WW; Cangialosi, J; Dartois, V; Dick, T; Negatu, DA | 1 |
Betoudji, F; Converse, PJ; Fotouhi, N; Lee, J; Li, SY; Mdluli, K; Nuermberger, EL; Upton, A | 1 |
Karkara, BB; Kumar, A; Panda, G | 1 |
Alffenaar, JWC; Migliori, GB; Peloquin, CA | 1 |
Cirrincione, KN; Deshpande, D; Gumbo, T; Koeuth, T; Lee, PS; Martin, KR; Nuermberger, E; Srivastava, S | 1 |
Fattorini, L; Giannoni, F; Iacobino, A; Pardini, M; Piccaro, G | 1 |
Martins Dos Santos, VAP; Rienksma, RA; Schaap, PJ; Suarez-Diez, M | 1 |
Ballante, F; Biava, M; Costi, R; De Vita, D; Di Santo, R; Feroci, M; Friggeri, L; Manetti, F; Musmuca, I; Ragno, R; Scipione, L; Tortorella, S | 1 |
Chan, RC; Kam, KM; Lam, ET; Yew, WW; Yip, PC | 1 |
Balasubramanian, V; Balganesh, M; Butler, SL; Deepthi, R; Ghosh, A; Iyer, H; Kaur, P; Melnick, D; Ramachandran, V; Ramya, V; Sambandamurthy, VK; Sharma, S; Solapure, S; Subbulakshmi, V; Wright, L | 1 |
Jeong, BH; Koh, WJ; Kwon, YS | 1 |
Liu, H; Liu, N; Wang, Y; Zhao, L | 1 |
Keum, YS; Park, SW; Patel, RV | 1 |
Bateman, C | 1 |
Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Vaja, MD | 1 |
Bruhn, DF; Lee, RE; Lenaerts, AJ; Liu, J; Scherman, MS; Singh, AP; Yang, L | 1 |
Benson, CA; Maartens, G | 1 |
Carniato, A; Fuser, R; Giobbia, M; Inojosa, WO; Rossi, C; Scotton, P; Torresan, S; Vaglia, A | 1 |
Grosset, JH; Nuermberger, E; Stover, CK; Tasneen, R; Tyagi, S; Williams, KN; Zhu, T | 1 |
Bozkurt, H; Cavusoglu, C; Erac, B; Ermertcan, S; Hosgor-Limoncu, M; Tasli, H | 1 |
Daley, CL | 1 |
Ginsberg, AM | 1 |
Vora, A | 1 |
Bedarida, G; Campbell, S; Jakubiec, W; Kumar, V; Ladutko, L; Miller, PF; Mitton-Fry, M; Paige, D; Silvia, A; Wallis, RS; Zhu, T | 1 |
Abdullah, ST; Azeeza, S; Kamal, A; Khan, IA; Khan, MN; Sharma, S; Shetti, RV; Swapna, P | 1 |
Adhikari, AV; Bhattacharya, B; Chowdhury, IH; Mahmood, R; Sandeep, T; Sumesh, E; Thomas, KD | 1 |
Bugaenko, SE; Elistratova, NA; Maliev, BM; Mozhokina, GN; Sokolova, GB; Solov'eva, IP | 1 |
Amoabeng, O; Andries, K; Mdluli, KE; Minkowski, A; Nuermberger, EL; Peloquin, CA; Taylor, D; Wallis, RS; Williams, K | 1 |
Bhattarai, D; Cho, SN; Kang, SB; Keum, G; Kim, EE; Lee, SH; Nam, G; Oh, T; Pae, AN; Seo, SH | 1 |
Anuradha, S; Kishan, V; Kumar, KS; Sarma, GR; Venkateshwarlu, Y | 1 |
López, M; Rodríguez, JC; Royo, G; Ruiz, M | 1 |
López, M; Rodriguez Díaz, JC; Royo, G; Ruiz, M | 1 |
KAMEYAMA, Y | 1 |
FORTUNI, M; MERENDA, P; MORETTI, E; SEDIARI, F | 1 |
Cebrián, L; Jiménez, I; López, M; Rodríguez, JC; Royo, G; Ruiz, M | 1 |
Cynamon, MH; DeStefano, MS; Monica, BJ; Shoen, CM; Sklaney, MR; Slee, AM | 1 |
Slebos, DJ; Van Altena, R | 1 |
Biava, M; Deidda, D; Pompei, R; Porretta, GC | 1 |
Barman, TK; Bhadauriya, T; Gautam, R; Malhotra, S; Rao, M; Rattan, A; Sood, R; Upadhyay, DJ | 1 |
Falagas, ME; Ntziora, F | 1 |
Escribano, I; García-Pachon, E; Llorca, B; Rodríguez, JC; Royo, G; Ruiz, M | 1 |
Bernal Ferrer, A; Sala Langa, MJ; Sequi Canet, JM | 1 |
Chen, BC; Chen, YS; Huang, TS; Liu, YC; Sy, CL; Tu, HZ | 1 |
Chase, S; Cynamon, MH; Klemens, SP; Sharpe, CA | 1 |
11 review(s) available for oxazolidin-2-one and Koch's Disease
Article | Year |
---|---|
Recent advances in oxazolidinones as antituberculosis agents.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Novel candidates in the clinical development pipeline for TB drug development and their synthetic approaches.
Topics: Adamantane; Animals; Antitubercular Agents; DNA Gyrase; Drug Development; Enzyme Inhibitors; Humans; Isonicotinic Acids; Mycobacterium tuberculosis; Oxazolidinones; Piperidines; Pyrroles; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant; Uridine | 2021 |
Tuberculosis: clinical trials and new drug regimens.
Topics: Acetamides; Adamantane; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; Drug Design; Ethylenediamines; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Nitroimidazoles, Quinolones and Oxazolidinones as Fluorine Bearing Antitubercular Clinical Candidates.
Topics: Animals; Antitubercular Agents; Drug Discovery; Fluorine; Humans; Nitroimidazoles; Oxazolidinones; Quinolones; Tuberculosis | 2015 |
Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives.
Topics: Animals; Antitubercular Agents; Drug Discovery; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis | 2015 |
Update in tuberculosis 2009.
Topics: Acetamides; Animals; Antitubercular Agents; Aza Compounds; Diarylquinolines; Fluoroquinolones; Humans; Linezolid; Mice; Moxifloxacin; Oxazolidinones; Quinolines; Rifampin; Tuberculosis; Tuberculosis Vaccines; Vitamin D; Vitamins | 2010 |
Tuberculosis drug development: progress, challenges, and the road ahead.
Topics: Antitubercular Agents; Drug Delivery Systems; Drug Design; Female; Fluoroquinolones; Humans; Male; Mycobacterium tuberculosis; Oxazolidinones; Rifamycins; Tuberculosis | 2010 |
New trends in development of antimycobacterial compounds.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Macrolides; Mycobacterium avium Complex; Mycobacterium Infections; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis | 2006 |
Antimycobacterial activities of oxazolidinones: a review.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Humans; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Oxazolidinones; Tuberculosis | 2006 |
Linezolid for the treatment of patients with [corrected] mycobacterial infections [corrected] a systematic review.
Topics: Acetamides; Adolescent; Adult; Anemia; Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Optic Nerve Diseases; Oxazolidinones; Peripheral Nervous System Diseases; Treatment Outcome; Tuberculosis | 2007 |
Linezolid.
Topics: Acetamides; Animals; Antitubercular Agents; Humans; Linezolid; Oxazolidinones; Treatment Outcome; Tuberculosis | 2008 |
2 trial(s) available for oxazolidin-2-one and Koch's Disease
Article | Year |
---|---|
Biomarker-assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis.
Topics: Acetamides; Adolescent; Adult; Animals; Antitubercular Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Rats; Serum Bactericidal Test; Treatment Outcome; Tuberculosis; Young Adult | 2011 |
Short-course treatment regimen to identify potential antituberculous agents in a murine model of tuberculosis.
Topics: Acetamides; Animals; Antitubercular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Fluoroquinolones; Gatifloxacin; Isoniazid; Linezolid; Mice; Mice, Inbred C57BL; Oxazolidinones; Rifampin; Time Factors; Tuberculosis | 2004 |
34 other study(ies) available for oxazolidin-2-one and Koch's Disease
Article | Year |
---|---|
A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Cutaneous Fistula; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Male; Meropenem; Micafungin; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Rifampin; Streptomycin; Teicoplanin; Tetrazoles; Tuberculosis | 2022 |
Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections.
Topics: Anti-Bacterial Agents; Humans; Linezolid; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Tuberculosis | 2023 |
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model.
Topics: Animals; Antitubercular Agents; Diarylquinolines; Linezolid; Mice; Nitroimidazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone.
Topics: Antitubercular Agents; Cycloserine; Humans; Isoxazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Multiparameter Responses to Tedizolid Monotherapy and Moxifloxacin Combination Therapy Models of Children With Intracellular Tuberculosis.
Topics: Anti-Bacterial Agents; Child; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Oxazolidinones; Tetrazoles; Tuberculosis | 2018 |
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Topics: Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Hypoxia; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis | 2019 |
Modeling Host-Pathogen Interaction to Elucidate the Metabolic Drug Response of Intracellular
Topics: Adenosine Triphosphatases; Amides; Amino Acids; Antitubercular Agents; Cycloserine; Diarylquinolines; Drug Tolerance; Ethambutol; Ethionamide; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Host-Pathogen Interactions; Humans; Isoniazid; Isoxazoles; Metabolic Networks and Pathways; Models, Biological; Mycobacterium bovis; Mycobacterium tuberculosis; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis | 2019 |
Pharmacophore assessment through 3-D QSAR: evaluation of the predictive ability on new derivatives by the application on a series of antitubercular agents.
Topics: Antitubercular Agents; Drug Design; Humans; Models, Molecular; Mycobacterium tuberculosis; Oxazolidinones; Pyrroles; Quantitative Structure-Activity Relationship; Tuberculosis | 2013 |
In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates.
Topics: Acetamides; Antitubercular Agents; Hong Kong; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis | 2013 |
Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis | 2014 |
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis from Shenyang, north of China.
Topics: Acetamides; Anti-Bacterial Agents; China; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
TB: the tap's down a notch – but the water's polluted.
Topics: Acetamides; Compassionate Use Trials; Congresses as Topic; Diarylquinolines; Drug Resistance, Multiple; Guidelines as Topic; Humans; Linezolid; Mycobacterium tuberculosis; Oxazolidinones; South Africa; Tuberculosis; Tuberculosis Vaccines; Tuberculosis, Multidrug-Resistant; Ventilation | 2014 |
Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids.
Topics: Animals; Antitubercular Agents; Chronic Disease; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Tuberculosis | 2016 |
Linezolid for Treating Tuberculosis: A Delicate Balancing Act.
Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Mycobacterium tuberculosis; Oxazolidinones; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Early linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis.
Topics: Acetamides; Acidosis, Lactic; Aged, 80 and over; Anti-Infective Agents; Discitis; Female; Humans; Linezolid; Lumbar Vertebrae; Mycobacterium tuberculosis; Oxazolidinones; Treatment Outcome; Tuberculosis | 2008 |
Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
Topics: Acetamides; Animals; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Linezolid; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis | 2009 |
In vitro activity of linezolid against Mycobacterium tuberculosis strains isoalted from Western Turkey.
Topics: Acetamides; Antitubercular Agents; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis; Turkey | 2009 |
Terizidone.
Topics: Antitubercular Agents; Humans; Isoxazoles; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones.
Topics: Antitubercular Agents; Cell Line; Cell Survival; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Sulfonamides; Tuberculosis | 2011 |
Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Catalytic Domain; Drug Design; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Humans; Models, Molecular; Mycobacterium tuberculosis; Oxazolidinones; Protein Binding; Quinolines; Tuberculosis | 2011 |
[Efficacy and tolerance of rezonizate in complex with fluoroquinolones or mycobutin on a model of experimental murine tuberculosis].
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Drug Therapy, Combination; Drug Tolerance; Fluoroquinolones; Gatifloxacin; Isoxazoles; Levofloxacin; Mice; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Rifabutin; Tuberculosis | 2011 |
Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
Synthesis and in vitro antibacterial activity of novel 3-azabicyclo[3.3.0]octanyl oxazolidinones.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cytochrome P-450 Enzyme System; Drug Design; Ether-A-Go-Go Potassium Channels; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium tuberculosis; Oxazolidinones; Structure-Activity Relationship; Triazoles; Tuberculosis | 2012 |
Screening, isolation, taxonomy and fermentation of an antibiotic producer Streptomyces xinghaiensis from soil capable of acting against linezolid resistant strains.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Artemia; Chromatography, High Pressure Liquid; Drug Resistance, Bacterial; Fermentation; Humans; Larva; Linezolid; Magnetic Resonance Spectroscopy; Molecular Structure; Mycobacterium tuberculosis; Neoplasms; Oxazolidinones; Phylogeny; Protein Synthesis Inhibitors; Soil; Soil Microbiology; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomyces; Toxicity Tests; Tuberculosis; Tumor Cells, Cultured | 2012 |
In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Linezolid; Male; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Quinolines; Tuberculosis | 2002 |
Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis | 2003 |
[Bacteriologic examination of sputum from tuberculous patients treated with antituberculous agent. I].
Topics: Bacteriology; Humans; Oxazolidinones; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[EEG study of patients of chronic pulmonary tuberculosis during D-4-amino-3-isoxazolidone (cycloserine) therapy].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Dermatologic Agents; Electroencephalography; Isoxazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis.
Topics: Acetamides; Anti-Infective Agents; Area Under Curve; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis | 2004 |
[Linezolid, an agent from a new class of antibiotics].
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Treatment Outcome; Tuberculosis | 2004 |
Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Ion Pumps; Linezolid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis | 2007 |
[Linezolid and tuberculosis, a new and useful treatment].
Topics: Acetamides; Anti-Infective Agents; Female; Humans; Infant; Linezolid; Oxazolidinones; Tuberculosis | 2008 |
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years.
Topics: Acetamides; Antitubercular Agents; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Taiwan; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2008 |
Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Antitubercular Agents; Female; Linezolid; Mice; Mycobacterium tuberculosis; Oxazoles; Oxazolidinones; Tuberculosis | 1999 |